These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1703345)
1. Infections in adult liver transplant patients under FK 506 immunosuppression. Alessiani M; Kusne S; Martin M; Jain A; Abu-Elmagd K; Moser J; Todo S; Fung J; Starzl T Transplant Proc; 1991 Feb; 23(1 Pt 2):1501-3. PubMed ID: 1703345 [No Abstract] [Full Text] [Related]
2. Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. Kusne S; Fung J; Alessiani M; Martin M; Torre-Cisneros J; Irish W; Ondick L; Jain A; Abu-Elmagd K; Takaya S Transplant Proc; 1992 Feb; 24(1):429-30. PubMed ID: 1371626 [No Abstract] [Full Text] [Related]
3. [Opportunistic infections in patients with collagen disease]. Tanaka Y; Saito K Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1654-9. PubMed ID: 15384698 [No Abstract] [Full Text] [Related]
4. Early trials with FK 506 as primary treatment in liver transplantation. Todo S; Fung JJ; Demetris AJ; Jain A; Venkataramanan R; Starzl TE Transplant Proc; 1990 Feb; 22(1):13-6. PubMed ID: 1689886 [No Abstract] [Full Text] [Related]
5. [Complications of hematopoietic stem cell transplantation and the treatment: infections]. Ishida Y; Sugawara T Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1344-50. PubMed ID: 16097590 [No Abstract] [Full Text] [Related]
6. Epidemiology and risk factors for late infection in solid organ transplant recipients. Cervera C; Fernández-Ruiz M; Valledor A; Linares L; Antón A; Ángeles Marcos M; Sanclemente G; Hoyo I; Cofán F; Ricart MJ; Pérez-Villa F; Navasa M; Pumarola T; Moreno A Transpl Infect Dis; 2011 Dec; 13(6):598-607. PubMed ID: 21535336 [TBL] [Abstract][Full Text] [Related]
7. A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates. Monden M; Gotoh M; Kanai T; Valdivia LA; Umeshita K; Endoh W; Nakano Y; Kawai M; Ohzato H; Ukei T Transplant Proc; 1990 Feb; 22(1):66-71. PubMed ID: 1689904 [No Abstract] [Full Text] [Related]
8. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Fung JJ; Todo S; Tzakis A; Demetris A; Jain A; Abu-Elmaged K; Alessiani M; Starzl TE Transplant Proc; 1991 Feb; 23(1 Pt 1):14-21. PubMed ID: 1703682 [No Abstract] [Full Text] [Related]
9. Infectious complications of pediatric liver transplantation under FK 506. Green M; Tzakis A; Reyes J; Nour B; Todo S; Starzl TE Transplant Proc; 1991 Dec; 23(6):3038-9. PubMed ID: 1721352 [No Abstract] [Full Text] [Related]
10. Clinical approach to viral and fungal infections in the renal transplant patient. Tolkoff-Rubin NE; Rubin RH Semin Nephrol; 1992 Jul; 12(4):364-75. PubMed ID: 1410863 [No Abstract] [Full Text] [Related]
11. Prophylaxis of opportunistic infections in individuals infected with HIV. Klein RS AIDS; 1989; 3 Suppl 1():S161-73. PubMed ID: 2514733 [No Abstract] [Full Text] [Related]
12. Immunosuppression withdrawal for treatment of severe infections in liver transplantation. Massarollo PC; Mies S; Abdala E; Leitão RM; Raia S Transplant Proc; 1998 Jun; 30(4):1472-4. PubMed ID: 9636598 [No Abstract] [Full Text] [Related]